SPIRIT III Data At EuroPCR Meeting Bodes Well For Abbott, Boston Scientific

Abbott and Boston Scientific are encouraged by new long-term data on their Xience V/Promus drug-eluting stent that was highlighted in the late-breaking trial results presented at the recent EuroPCR conference in Barcelona